Birzeit Pharmaceutical Company Achieves Record Profits in the First Half of 2025 Approaching 8 Million Dollars

Economy SadaNews - The financial data disclosed by Birzeit Pharmaceutical Company for the first half of 2025 shows a significant improvement in performance, with profits nearing 8 million dollars. This is largely attributed to a substantial increase in sales, with a growth rate of approximately 29% compared to the first half of 2024.

The important element that demonstrates management's efficiency in cost management is the profit margin, which reached 34% in the first half of 2025. Other important factors that enhance the company's profitability include profits derived from currency differences, as the decline in the dollar's value against the shekel improves the company's profitability, especially for local sales priced in shekels. It is expected that in the coming period, the dollar exchange rate against the shekel will remain at suitable levels for the company to maintain continuous profitability growth.

It is important to note the management's ability to control expenses and costs, as selling expenses decreased by 30% compared to the same period in 2024. This indicates that the company and its management are working to achieve growth in the company and its fair value. The company is trading at a market share price of 3.60 dollars per share, with a book value based on the first half data reaching 2.80 dollars per share. The earnings per share stood at 20 cents in the first half of 2025 compared to 0.001 in the first half of 2024.

When using valuation models to calculate the fair value of the stock based on a growth-based pricing model, the fair value of the share is higher than the market value at which it is trading at 3.60 dollars per share. This is due to the significant improvement in profitability in recent periods as a result of increased export sales and improved profit margins.

The company achieved positive net operating cash flows exceeding 2 million dollars during the first half of 2025, which is an excellent indicator of the company's ability to generate sustainable future profits for the coming years and raises the fair value of the share.